Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Pill count is an independent predictor of achieving complete cytogenetic response (ccyr) and european leukemianet (eln) optimal response (optr) in patients (pt) with cml treated with imatinib
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Poster
- By: ABRAHAM, Ivo (University Of Arizona, Pharmacy Practice and Science, Tucson, United States)
- Co-author(s): Shreya Gupta: University Of Arizona, Tucson, United States
Karen MacDonald: Matrix45, Tucson, United States
Ivo Abraham: Pharmacy Practice and Science, University Of Arizona College of Pharmacy, Tucson, United States
BackgroundThe ADAGIO study (Noens et al, Blood 2009) on adherence to imatinib in CML pts reported pill count rates between 29% to 202% of pills taken pills prescribed for a mean(+SD) of 90.1(+20.1)%. We examined whether pill count was predictive of CCyR and OptR.
PurposeTo determine whether pill count is predictive of CCyR and OptR.
MethodsWe.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019